Carlo Avolio

3.1k total citations
75 papers, 1.8k citations indexed

About

Carlo Avolio is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Carlo Avolio has authored 75 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pathology and Forensic Medicine, 14 papers in Molecular Biology and 14 papers in Immunology. Recurrent topics in Carlo Avolio's work include Multiple Sclerosis Research Studies (30 papers), Cell Adhesion Molecules Research (10 papers) and Peripheral Neuropathies and Disorders (8 papers). Carlo Avolio is often cited by papers focused on Multiple Sclerosis Research Studies (30 papers), Cell Adhesion Molecules Research (10 papers) and Peripheral Neuropathies and Disorders (8 papers). Carlo Avolio collaborates with scholars based in Italy, United States and United Kingdom. Carlo Avolio's co-authors include María Trojano, Paolo Livrea, Fabrizio Giuliani, Maddalena Ruggieri, Grazia Maria Liuzzi, Paolo Riccio, Francesca De Robertis, Damiano Paolicelli, Maria Liguori and Gianluca Iacobellis and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Carlo Avolio

69 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlo Avolio Italy 22 680 398 306 298 286 75 1.8k
J. Steven Alexander United States 23 214 0.3× 502 1.3× 171 0.6× 335 1.1× 195 0.7× 36 1.4k
Robert Moumdjian Canada 29 264 0.4× 784 2.0× 415 1.4× 443 1.5× 635 2.2× 65 3.0k
Bernadette Kálmán United States 26 723 1.1× 932 2.3× 214 0.7× 483 1.6× 211 0.7× 83 2.0k
Björn Tackenberg Germany 25 843 1.2× 614 1.5× 350 1.1× 761 2.6× 845 3.0× 74 2.8k
Chuanzhen Lü China 31 561 0.8× 679 1.7× 166 0.5× 342 1.1× 899 3.1× 87 2.5k
Naoyuki Tanuma Japan 25 319 0.5× 381 1.0× 193 0.6× 644 2.2× 177 0.6× 66 1.7k
Catherine Larochelle Canada 25 579 0.9× 498 1.3× 250 0.8× 614 2.1× 218 0.8× 60 1.9k
Anne Waschbisch Germany 21 496 0.7× 420 1.1× 165 0.5× 501 1.7× 195 0.7× 46 1.5k
Sun On Chan Hong Kong 29 383 0.6× 955 2.4× 303 1.0× 236 0.8× 95 0.3× 147 2.5k
Hans Hartung Germany 19 597 0.9× 375 0.9× 651 2.1× 208 0.7× 396 1.4× 56 2.0k

Countries citing papers authored by Carlo Avolio

Since Specialization
Citations

This map shows the geographic impact of Carlo Avolio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlo Avolio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlo Avolio more than expected).

Fields of papers citing papers by Carlo Avolio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlo Avolio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlo Avolio. The network helps show where Carlo Avolio may publish in the future.

Co-authorship network of co-authors of Carlo Avolio

This figure shows the co-authorship network connecting the top 25 collaborators of Carlo Avolio. A scholar is included among the top collaborators of Carlo Avolio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlo Avolio. Carlo Avolio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Filippi, Massimo, Maria Pia Amato, Carlo Avolio, et al.. (2025). Towards a biological view of multiple sclerosis from early subtle to clinical progression: an expert opinion. Journal of Neurology. 272(2). 179–179. 3 indexed citations
3.
Zanghì, Aurora, et al.. (2025). Comparing STRATIFY JCV™ DxSelect™ and IMMUNOWELL™ JCV Tests in RRMS to Assess PML Risk. Current Neuropharmacology. 23(10). 1294–1300. 1 indexed citations
4.
Zanghì, Aurora, Roberta Fantozzi, Matteo Foschi, et al.. (2025). Identifying Cladribine prescription pattern in MS: an Italian multicentre study. Therapeutic Advances in Neurological Disorders. 18. 4233585300–4233585300.
5.
Sangineto, Moris, Archana Moola, Vidyasagar Naik Bukke, et al.. (2024). Krebs cycle derivatives, dimethyl fumarate and itaconate, control metabolic reprogramming in inflammatory human microglia cell line. Mitochondrion. 79. 101966–101966. 2 indexed citations
6.
Rocchetti, Maria Teresa, Giuseppe Spano, Pasquale Russo, et al.. (2024). Lactobacilli Cell-Free Supernatants Modulate Inflammation and Oxidative Stress in Human Microglia via NRF2-SOD1 Signaling. Cellular and Molecular Neurobiology. 44(1). 60–60. 8 indexed citations
7.
Zanghì, Aurora, et al.. (2023). MiRNA 106a-5p in cerebrospinal fluid as signature of early relapsing remitting multiple sclerosis: a cross sectional study. Frontiers in Immunology. 14. 1226130–1226130. 3 indexed citations
8.
Sangineto, Moris, Tommaso Cassano, Archana Moola, et al.. (2023). Metabolic reprogramming in inflammatory microglia indicates a potential way of targeting inflammation in Alzheimer's disease. Redox Biology. 66. 102846–102846. 64 indexed citations
9.
Villani, Rosanna, Gaetano Serviddio, Carlo Avolio, Tommaso Cassano, & Emanuele D’Amico. (2023). Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives. Clinical and Experimental Medicine. 23(7). 3321–3338. 9 indexed citations
10.
Rodolico, Alessandro, Maria Salvina Signorelli, Antonino Petralia, et al.. (2023). Personality Traits and Fatigue in Multiple Sclerosis: A Narrative Review. Journal of Clinical Medicine. 12(13). 4518–4518. 6 indexed citations
11.
Laselva, Onofrio, et al.. (2021). Anti-Inflammatory and Anti-Oxidant Effect of Dimethyl Fumarate in Cystic Fibrosis Bronchial Epithelial Cells. Cells. 10(8). 2132–2132. 14 indexed citations
12.
Mundi, Ciro, et al.. (2020). Interaction between Cognitive Reserve and Biomarkers in Alzheimer Disease. International Journal of Molecular Sciences. 21(17). 6279–6279. 16 indexed citations
13.
D’Orsi, G., Orazio Palumbo, Annarita Sabetta, et al.. (2020). The presenting symptoms of Lafora Disease: An electroclinical and genetic study in five Apulian (Southern Italy) families. Seizure. 83. 145–153. 5 indexed citations
15.
D’Orsi, G., et al.. (2016). Intravenous lacosamide in seizure emergencies: Observations from a hospitalized in-patient adult population. Seizure. 42. 20–28. 14 indexed citations
16.
Ruggieri, Maddalena, Annamaria Lia, Giovanni Bosco Zimatore, et al.. (2008). Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients. Journal of Neuroimmunology. 197(2). 140–146. 21 indexed citations
17.
Franciotta, Diego, Carlo Avolio, Elisabetta Capello, & Francesco Lolli. (2005). Consensus recommendations of the Italian Association for Neuroimmunology for immunochemical cerebrospinal fluid examination. Journal of the Neurological Sciences. 237(1-2). 5–11. 10 indexed citations
18.
Avolio, Carlo, Maddalena Ruggieri, Fabrizio Giuliani, et al.. (2003). Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes. Journal of Neuroimmunology. 136(1-2). 46–53. 154 indexed citations
19.
Avolio, Carlo, Maddalena Ruggieri, Paola Cafforio, et al.. (2001). LFA-1 expression on CD4+CD45RO+ peripheral blood T-lymphocytes in RR MS: effects induced by rIFNβ-1a. Journal of the Neurological Sciences. 186(1-2). 65–73. 5 indexed citations
20.
Trojano, María, Carlo Avolio, A Calò, et al.. (1995). Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events.. Journal of Neurology Neurosurgery & Psychiatry. 58(3). 300–306. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026